BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 21941835)

  • 1. [Our role in sentinel surveillance for drug resistance in leprosy by global leprosy programme].
    Matsuoka M
    Nihon Hansenbyo Gakkai Zasshi; 2011 Sep; 80(3):287-91. PubMed ID: 21941835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Review of sentinel surveillance for drug resistance in leprosy conducted by WHO Global Leprosy Programme].
    Matsuoka M
    Nihon Hansenbyo Gakkai Zasshi; 2011 Feb; 80(1):71-7. PubMed ID: 21404598
    [No Abstract]   [Full Text] [Related]  

  • 3. Report of the WHO workshop on sentinel surveillance for drug resistance in leprosy 20-22 october 2008; Hanoi, Vietnam.
    Indian J Lepr; 2009; 81(1):43-54. PubMed ID: 20329363
    [No Abstract]   [Full Text] [Related]  

  • 4. [Report of the Ninth meeting of the WHO Technical Advisory Group of Leprosy Control].
    Ishii N; Mori S; Nagaoka Y; Suzuki K
    Nihon Hansenbyo Gakkai Zasshi; 2009 Feb; 78(1):75-88. PubMed ID: 19227153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taking home lessons from the 15th International Leprosy Congress.
    Lechat MF
    Int J Lepr Other Mycobact Dis; 1998 Dec; 66(4):562-6. PubMed ID: 10347572
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular detection of drug resistance in Mycobacterium leprae.
    Williams DL; Gillis TP
    Lepr Rev; 2004 Jun; 75(2):118-30. PubMed ID: 15282962
    [No Abstract]   [Full Text] [Related]  

  • 7. [Report of the tenth meeting of the WHO Technical Advisory Group on Leprosy Control].
    Ishii N; Barua S; Mori S; Nagaoka Y; Suzuki K
    Nihon Hansenbyo Gakkai Zasshi; 2010 Feb; 79(1):37-42. PubMed ID: 20169983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary multidrug-resistant leprosy, United States.
    Williams DL; Hagino T; Sharma R; Scollard D
    Emerg Infect Dis; 2013 Jan; 19(1):179-81. PubMed ID: 23260417
    [No Abstract]   [Full Text] [Related]  

  • 9. Time to define leprosy elimination as zero leprosy transmission?
    Smith CS; Aerts A; Kita E; Virmond M
    Lancet Infect Dis; 2016 Apr; 16(4):398-9. PubMed ID: 27036335
    [No Abstract]   [Full Text] [Related]  

  • 10. Viability and drug sensitivity of M. leprae isolated from long-term WHO/MDT treated multibacillary leprosy patients.
    Habtemariam H
    Lepr Rev; 1999 Mar; 70(1):43-6. PubMed ID: 10405543
    [No Abstract]   [Full Text] [Related]  

  • 11. Progress in the chemotherapy of leprosy.
    Grosset JH
    Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):268-77. PubMed ID: 8046266
    [No Abstract]   [Full Text] [Related]  

  • 12. A quantitative basis for sustainable anti-Mycobacterium leprae chemotherapy in leprosy control programs.
    Almeida JG
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):255-68. PubMed ID: 1522367
    [No Abstract]   [Full Text] [Related]  

  • 13. Multidrug resistant Mycobacterium leprae from patients with leprosy.
    Maeda S; Matsuoka M; Nakata N; Kai M; Maeda Y; Hashimoto K; Kimura H; Kobayashi K; Kashiwabara Y
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3635-9. PubMed ID: 11709358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case Report: Multidrug-Resistant
    Kamat D; Narang T; Ahuja M; Lavania M; Dogra S
    Am J Trop Med Hyg; 2020 Apr; 102(4):724-727. PubMed ID: 32043454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Search for effective short-course regimens for the treatment of leprosy.
    Pattyn SR
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):76-81. PubMed ID: 8326183
    [No Abstract]   [Full Text] [Related]  

  • 16. Dormancy, drug resistance or dependency; some thoughts to ponder.
    Shetty VP; Mistry NF; Uplekar MW; Antia NH; Pai VV; Ganapati R
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):455-7. PubMed ID: 9030116
    [No Abstract]   [Full Text] [Related]  

  • 17. Does dapsone resistance really matter in the MDT era?
    Ji B
    Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):54-5. PubMed ID: 11480322
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug-resistant leprosy: monitoring and current status.
    Williams DL; Gillis TP
    Lepr Rev; 2012 Sep; 83(3):269-81. PubMed ID: 23356028
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug resistance in leprosy: lessons from past and future perspective.
    Gupta UD; Katoch VM
    Indian J Lepr; 1999; 71(4):451-63. PubMed ID: 10804973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research in developing countries: will leprosy vaccine be produced in Nepal?].
    Kurlberg G
    Nord Med; 1990; 105(12):338-9. PubMed ID: 2270200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.